135 related articles for article (PubMed ID: 3180706)
1. Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus.
Chow AW; Wong J; Bartlett KH
Diagn Microbiol Infect Dis; 1988 Apr; 9(4):213-7. PubMed ID: 3180706
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia.
Chow AW; Wong J; Bartlett KH
Antimicrob Agents Chemother; 1988 May; 32(5):782-4. PubMed ID: 3395107
[TBL] [Abstract][Full Text] [Related]
3. Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.
Chow AW; Wong J; Bartlett KH; Shafran SD; Stiver HG
Antimicrob Agents Chemother; 1989 Aug; 33(8):1368-72. PubMed ID: 2508546
[TBL] [Abstract][Full Text] [Related]
4. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
5. In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa.
Meyer RD; Liu S
Diagn Microbiol Infect Dis; 1988 Nov; 11(3):151-7. PubMed ID: 3149927
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.
Marques MB; Brookings ES; Moser SA; Sonke PB; Waites KB
Antimicrob Agents Chemother; 1997 May; 41(5):881-5. PubMed ID: 9145838
[TBL] [Abstract][Full Text] [Related]
7. Comparison of susceptibility of gentamicin-resistant and -susceptible "Acinetobacter anitratus" to 15 alternative antibiotics.
Stiver HG; Bartlett KH; Chow AW
Antimicrob Agents Chemother; 1986 Oct; 30(4):624-5. PubMed ID: 3789698
[TBL] [Abstract][Full Text] [Related]
8. In-vitro susceptibility of clinical isolates of Serratia species to antimicrobial agents.
Sofianou D; Proya E; Kondodimou A
J Chemother; 1990 Apr; 2(2):79-81. PubMed ID: 2362189
[TBL] [Abstract][Full Text] [Related]
9. Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.
Bello H; Gonzalez G; Dominguez M; Zemelman R; Garcia A; Mella S
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):183-6. PubMed ID: 9327246
[TBL] [Abstract][Full Text] [Related]
10. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
Medeiros AA; Hare R; Papa E; Adam C; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
Lyon MD; Smith KR; Saag MS; Cloud GA; Cobbs CG
Antimicrob Agents Chemother; 1986 Jul; 30(1):25-30. PubMed ID: 3092731
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii.
Shi ZY; Liu PY; Lau Y; Lin Y; Hu BS; Shir J-M
Diagn Microbiol Infect Dis; 1996 Feb; 24(2):81-5. PubMed ID: 9147913
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
Kropec A; Daschner F
Chemotherapy; 1989; 35(5):360-2. PubMed ID: 2507235
[TBL] [Abstract][Full Text] [Related]
14. [In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis].
Croize J; Gout JP; Robert J; Le Noc P
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):573-7. PubMed ID: 2508041
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides.
Joly-Guillou ML; Decré D; Herrman JL; Bourdelier E; Bergogne-Bérézin E
J Antimicrob Chemother; 1995 Oct; 36(4):619-29. PubMed ID: 8591936
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.
Giamarellou H; Zissis NP; Tagari G; Bouzos J
Antimicrob Agents Chemother; 1984 Apr; 25(4):534-6. PubMed ID: 6428310
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of antimicrobial agents against Acinetobacter calcoaceticus.
Joly-Guillou ML; Bergogne-Berezin E
Drugs Exp Clin Res; 1986; 12(12):949-52. PubMed ID: 3471431
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Acinetobacter calcoaceticus to antimicrobial drugs, alone and combined, with and without defibrinated human blood.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1989; 35(2):95-104. PubMed ID: 2758872
[TBL] [Abstract][Full Text] [Related]
19. Cross resistance to ciprofloxacin and other antimicrobial agents among clinical isolates of Acinetobacter calcoaceticus biovar anitratus.
Shalit I; Dan M; Gutman R; Gorea A; Berger SA
Antimicrob Agents Chemother; 1990 Mar; 34(3):494-5. PubMed ID: 2185692
[TBL] [Abstract][Full Text] [Related]
20. In vitro interactions of aminoglycosides with imipenem or ciprofloxacin against aminoglycoside resistant Acinetobacter baumannii.
Xirouchaki E; Giamarellou H
J Chemother; 1992 Oct; 4(5):263-7. PubMed ID: 1479414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
